EMR vs DOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

EMR

39.1
AI Score
VS
DOV Wins

DOV

50.5
AI Score

Investment Advisor Scores

EMR

39score
Recommendation
AVOID NEW MONEY

DOV

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EMR DOV Winner
Forward P/E 21.4592 16.8919 DOV
PEG Ratio 1.7818 1.4696 DOV
Revenue Growth 7.0% 6.9% EMR
Earnings Growth 23.0% 14.1% EMR
Tradestie Score 39.1/100 50.5/100 DOV
Profit Margin 13.8% 13.5% EMR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD DOV

Relative Price Performance (Last 90 Days)

EMR 1M: +8.5% · 3M: +14.2% DOV 1M: +0.4% · 3M: -11.7%

Current Technical Phase

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.6% over 20 days), RSI 63

RSI (14): 62.8 · Price: $161.61

DOV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.0%), weak momentum, RSI 45

RSI (14): 44.7 · Price: $189.69

Fundamentals Snapshot

Metric EMR DOV
Market Cap — —
Forward P/E 22.2 16.3
Trailing P/E 33.9 22.6
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.4%
Operating Margin 0.3% 0.2%
EPS 4.68 8.31
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, DOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.